100 related articles for article (PubMed ID: 30882636)
1. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
[TBL] [Abstract][Full Text] [Related]
2. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
[TBL] [Abstract][Full Text] [Related]
4. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D.
Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C
Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population.
Zhou J; Xu L; Pan J; Wang M; Zhou P; Wang W; Lu S; Zhu W
Qual Life Res; 2024 Jan; 33(1):113-122. PubMed ID: 37695478
[TBL] [Abstract][Full Text] [Related]
7. Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.
Xu RH; Luo N; Dong D
Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38472723
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.
Xie S; Wu J; Chen G
Eur J Health Econ; 2024 Feb; 25(1):7-19. PubMed ID: 36709458
[TBL] [Abstract][Full Text] [Related]
9. The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes.
Mulhern B; Meadows K
Health Qual Life Outcomes; 2014 Mar; 12():42. PubMed ID: 24661350
[TBL] [Abstract][Full Text] [Related]
10. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
Dritsaki M; Petrou S; Williams M; Lamb SE
Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China.
Ding N; Zhou H; Chen C; Chen H; Shi Y
Appl Health Econ Health Policy; 2024 Jul; 22(4):555-568. PubMed ID: 38641755
[TBL] [Abstract][Full Text] [Related]
12. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
[TBL] [Abstract][Full Text] [Related]
13. Scale agreement, ceiling and floor effects, construct validity, and relative efficiency of the PROPr and EQ-5D-3L in low back pain patients.
Klapproth CP; Fischer F; Rose M
Health Qual Life Outcomes; 2023 Sep; 21(1):107. PubMed ID: 37759272
[TBL] [Abstract][Full Text] [Related]
14. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
Nikl A; Janssen MF; Jenei B; Brodszky V; Rencz F
Pharmacoeconomics; 2024 May; 42(5):583-603. PubMed ID: 38416366
[TBL] [Abstract][Full Text] [Related]
15. [Comparison Between EuroQol Five-Dimensional Questionnaire and Short-Form 6-Dimension Health Survey for the Populations in China:A Scoping Review].
Zhang AX; Mao ZX; Wang P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Aug; 45(4):655-665. PubMed ID: 37654146
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
Monroy M; Ruiz MA; Rejas J; Soto J
Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
[TBL] [Abstract][Full Text] [Related]
17. EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.
Xu RH; Lu M; Zhang S; Dong D
Eur J Health Econ; 2023 Nov; 24(8):1399-1410. PubMed ID: 36418784
[TBL] [Abstract][Full Text] [Related]
18. Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L.
Huang W; Yu H; Liu C; Liu G; Wu Q; Zhou J; Zhang X; Zhao X; Shi L; Xu X
Int J Environ Res Public Health; 2017 Feb; 14(3):. PubMed ID: 28241507
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS).
Shah HA; Dritsaki M; Pink J; Petrou S
Health Qual Life Outcomes; 2016 Jan; 14():15. PubMed ID: 26818098
[TBL] [Abstract][Full Text] [Related]
20. Properties of patient-reported outcome measures in individuals following acute whiplash injury.
Pink J; Petrou S; Williamson E; Williams M; Lamb SE
Health Qual Life Outcomes; 2014 Mar; 12():38. PubMed ID: 24625124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
